Long non-coding RNA TUG1 is involved in the development and progression of a variety of
tumors. Little is known about TUG1 function in high-grade muscle-invasive bladder cancer (…

Available systemic treatment options for cancers of the genitourinary system have experienced
great progress in the last decade. However, a large proportion of patients eventually …

Simple Summary Current diagnostics of prostate cancer often show unsatisfactory results,
leading to delayed detection or overtreatment. Urinary microRNAs are a class of promising non…

IntroductionUrinary microRNAs (miRNAs) are emerging as a clinically useful tool for early
and non-invasive detection of various types of cancer. The aim of this study was to evaluate …

Esophageal adenocarcinoma (EAC) is highly aggressive malignancy that frequently develops
from Barrett’s esophagus (BE), a premalignant pathologic change occurring in the lower …

Renal cell carcinoma (RCC) is a relatively rare malignancy of the urinary tract system. RCC
is a heterogenous disease in terms of underlying histology and its associated underlying …

Urinary micro RNA s (mi RNA s) are emerging as clinically useful tool for early and non‐invasive
detection of various types of cancer including bladder cancer ( BCA ). In this study, 205 …

Purpose To provide information about the role of microRNAs in the pathogenesis of renal
cell carcinoma (RCC) and their diagnostic and prognostic utility as cancer biomarkers. …

The discovery of non-coding RNAs (ncRNAs) and their role in tumor onset and progression
has revolutionized the way scientists and clinicians study cancers. This discovery opened …

Associated with the pathogenesis of many cancers, including brain tumors, microRNAs (miRNAs)
present promising diagnostic biomarkers. These molecules have been also studied in …